Inventor · disambiguated record
Anita Seto
Also filed as: SETO ANITA · SETO ANITA G
7 granted patents·5 pending applications·17 citations·filing 2009–2019
80Inventor score
Top patents by PatentIndex Score
12 records- 0190US9771585B2miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)MIRAGEN THERAPEUTICS INC·Filed 2016·Granted Sep 26, 2017·7 cites·12 claims
- 0282US9994852B2Oligonucleotide compositions and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2017·Granted Jun 12, 2018·1 cites·15 claims
- 0378US9163235B2Inhibitors of the miR-15 family of micro-RNAsMIRAGEN THERAPEUTICS·Filed 2013·Granted Oct 20, 2015·7 cites·17 claims
- 0476US9885042B2miR-92 inhibitors and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2016·Granted Feb 6, 2018·2 cites·19 claims
- 0571US2019359980A1Oligonucleotide compositions and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0670US10316318B2Oligonucleotide compositions and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2018·Granted Jun 11, 2019·0 cites·16 claims
- 0759US2011160285A1Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathyUNIV COLORADO·Filed 2009·Application pending·0 cites
- 0857US10280422B2MiR-92 inhibitors and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·0 cites·42 claims
- 0957US2018127750A1Mir-155 inhibitors for treating cutaneous t cell lymphoma (ctcl)MIRAGEN THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1054US2019194662A1Mir-92 inhibitors and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1147US9752143B2Locked nucleic acid inhibitor of miR-145 and uses thereofMIRAGEN THERAPEUTICS INC·Filed 2014·Granted Sep 5, 2017·0 cites·19 claims
- 1238US2014024700A1Blood-borne mirnas as surrogate markers of drug efficacy for cardiac conditionsVAN ROOIJ EVA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anita Seto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →